methyl <1α,2α(Z),3α,4α>-7-<3-formyl-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoate | 104596-33-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl <1α,2α(Z),3α,4α>-7-<3-formyl-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoate
• 英文别名: methyl (5Z)-7-(3-exo-formyl-7-oxabicyclo<2.2.1>heptan-2-exo-yl)hept-5-enoate；methyl (1α,2α(Z),3α,4α)-7-(3-formyl-7-oxabicyclo[2.2.1]hept-2-yl)-5-heptenoate；methyl (Z)-7-[(1S,2R,3S,4R)-3-formyl-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoate
• CAS: 104596-33-0
• 化学式: C₁₅H₂₂O₄
• 分子量: 266.337
• InChiKey: KLYPOSMZOMHLMJ-JIEOEBJZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.27
• 重原子数：
  19.0
• 可旋转键数：
  7.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  52.6
• 氢给体数：
  0.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  methyl <1α,2α(Z),3α,4α>-7-<3-formyl-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoate 在 lithium hydroxide 、 sodium tetrahydroborate 、 copper(l) iodide 、 cerium(III) chloride 、 amberlyst-15 resin 、 双氧水 、 sodium hydride 、 对甲苯磺酸 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 118.67h， 生成 <1S<1α,2α(Z),3α(E,3S^*,4R^*),4α>>-7-<3-(3-hydroxy-4-phenyl-1-pentenyl)-7-oxabicyclo<2.2.1>hept-2-yl>-3-methyl-5-heptenoic acid
  参考文献：
  名称：

  9,11-Epoxy-9-homoprosta-5-enoic acid analogs as thromboxane A2 receptor antagonists

  摘要：

  A novel bicyclic prostaglandin analogue, (1S)-[1 alpha, 2 alpha(Z),3 alpha(1E,3S*,4R*),4 alpha]-7-[3-(3-hydroxy-4-phenyl-1-pentenyl)-7- oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (4), was found to be a potent and selective thromboxane A2 (TxA2) receptor antagonist. Alcohol 4 was the only member in a series of allylic alcohols which did not display direct contractile activity in the rat stomach strip model. Alcohol 4 was effective in the inhibition of (a) arachidonic acid induced platelet aggregation of human platelet-rich plasma (I50 = 0.65 +/- 0.1 microM); (b) 11,9-epoxymethano-PGH2 induced contraction of guinea pig trachea (pA2 = 8.0 +/- 0.2) or rat aorta (pA2 = 8.1 +/- 0.2); and (c) arachidonic acid induced bronchoconstriction in the anesthetized guinea pig (1 mg/kg iv). A radioiodinated analogue of 4 bound in a specific and saturable manner to human platelet membranes with a Kd = 2.3 +/- 0.9 nM. Modification of the alpha-chain, in an attempt to minimize in vivo metabolism, resulted in TxA2 receptor antagonists of reduced in vitro potency.

  DOI：

  10.1021/jm00168a032
• 作为产物：
  描述：

  [1S-[1α,2α(Z),3α,4α]]-7-[3-(Hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid 在 草酰氯 、 三乙胺 作用下， 以 乙醚 为溶剂， 反应 1.0h， 生成 methyl <1α,2α(Z),3α,4α>-7-<3-formyl-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoate
  参考文献：
  名称：

  血栓烷A2受体拮抗剂。I.具有苯磺酰基氨基的7-氧杂双环-[2.2.1]庚烷衍生物的合成和药理活性。

  摘要：

  合成了具有苯磺酰基氨基基团的7-氧杂双环[2.2.1]庚烷衍生物的四种立体异构体，分别在体外检查了其钠盐对兔富含血小板血浆和大鼠聚集的抑制活性洗净的血小板。反式异构体23显示出高效力，但显示出部分激动作用。尽管化合物11是活性较低的抑制剂，但它没有显示出部分激动作用。合成了以下反式化合物，并测量了其IC50值：具有一个亚甲基链的同系反式异构体（47和53），烯烃衍生物（58）和光学活性衍生物[-]-11和（+）-23） 。

  DOI：

  10.1248/cpb.37.327

文献信息

• 7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza .omega.-chain analogs
  作者：Masami Nakane、Joyce A. Reid、Wen Ching Han、Jagabandhu Das、Vu Chi Truc、Martin F. Haslanger、Dianne Garber、Don N. Harris、Anders Hedberg、Martin L. Ogletree、Steven E. Hall

  DOI：10.1021/jm00171a021

  日期：1990.9.1

  A novel bicyclic prostaglandin analogue, [1S-[1 alpha, 2 alpha (Z), 3 alpha, 4 alpha]]-7-[3-[[[[(1- Oxoheptyl)amino]acetyl]amino]-methyl]-7-oxabicyclo[2.2.1]hept-2- yl]-5-heptenoic acid [-)-7) was found to be a potent and selective thromboxane A2 (TxA2) receptor antagonist. Unlike the related series of omega-chain allylic alcohols, amide 7 and its congeners were uniformly free of direct contractile

  新型的双环前列腺素类似物，[1S- [1 alpha，2 alpha（Z），3 alpha，4 alpha]]-7- [3-[[[[[（[Oxoheptyl）amino] acetyl] amino] -methyl]发现-7-氧杂双环[2.2.1]庚-2-基] -5-庚烯酸[-]-7是有效的选择性血栓烷A2（TxA2）受体拮抗剂。与相关系列的ω-链烯丙基醇不同，酰胺7及其同类物在体外（牛冠状动脉）和体内（麻醉的豚鼠）均一致没有直接收缩活性。酰胺7有效抑制（a）花生四烯酸诱导的人血小板丰富血浆的血小板聚集（I50 = 0.18 +/- 0.006 microM），（b）11,9-环氧甲氧基-PGH2诱导的人血小板血小板聚集-血浆（I50 = 0.24 microM），（c）11,9-环氧甲氧基-PGH2诱导的豚鼠气管（Kb = 3.0 +/- 0.3 nM）或大鼠主动脉（Kb = 8.8 +/-
• Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogs of thromboxane A2/PGH2
  作者：P. W. Sprague、J. E. Heikes、J. Z. Gougoutas、M. F. Malley、D. N. Harris、R. Greenberg

  DOI：10.1021/jm00149a007

  日期：1985.11

  A series of chemically stable TXA2/PGH2 analogues modeled after the structure of the natural products was prepared in search of useful inhibitors of TXA2/PGH2-mediated pathophysiology. Each of the 16 isomers implied in structure 1 was prepared in chiral form and evaluated for activity in vitro in platelets and smooth muscle. Depending on relative side chain and carbinol stereochemistry, TXA2/PGH2 agonist

  为了寻找有用的TXA2 / PGH2介导的病理生理抑制剂，制备了一系列以天然产物的结构为模型的化学稳定的TXA2 / PGH2类似物。以手性形式制备结构1所示的16种异构体，并评估其在血小板和平滑肌中的体外活性。根据相对的侧链和甲醇的立体化学，观察到TXA2 / PGH2激动剂和拮抗剂，以及令人惊讶的是PGD2 / PGI2激动剂活性。具有1所示的α杂环的对映体通常比其镜像异构体更有效。
• 9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase
  作者：Steven E. Hall、Wen Ching Han、Martin F. Haslanger、Don N. Harris、Martin L. Ogletree

  DOI：10.1021/jm00161a032

  日期：1986.11

  A novel bicyclic prostaglandin analogue, [1R-[l alpha,2 beta (5Z),3 beta,4 alpha]]-7-[3-[(hexyloxy)methyl]- 7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (1), and cogeners were found to be potent inhibitors of fatty acid cyclooxygenase. Compound 1 was the only stereoisomer out of eight possible structures that was active. Ether 1 was 20 times more potent than indomethacin (IND) in inhibiting arachidonic acid (AA) induced aggregation of human platelet-rich plasma. Compound 1 was also more potent than IND in several in vivo assays, AA-induced sudden death in the conscious mouse (2 times) and AA-induced bronchoconstriction in the anesthetized guinea pig (16-45 times).
• DAS, JAGABANDHU;HALL, STEVEN E.;NAKANE, MASAMI;HASLANGER, MARTIN F.;REID,+, J. MED. CHEM., 33,(1990) N, C. 1741-1748
  作者：DAS, JAGABANDHU、HALL, STEVEN E.、NAKANE, MASAMI、HASLANGER, MARTIN F.、REID,+

  DOI：——

  日期：——
• NAKANE, MASARNI;REID, JOYCE A.;HAN, WEN-CHING;DAS, JAGABANDHU;TRUC, VU CH+, J. MED. CHEM., 33,(1990) N, C. 2465-2476
  作者：NAKANE, MASARNI、REID, JOYCE A.、HAN, WEN-CHING、DAS, JAGABANDHU、TRUC, VU CH+

  DOI：——

  日期：——